Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Who knows what ? When or how?

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on Jun 13, 2023 10:53am

133 Views

Post# 35493592

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Who knows what ? When or how?

Hey Quentin....seeing as you're so self-proclaimed brilliant, tell us, did you sell these so-called "trading stocks" before yesterday's run up of 18%, or before today's 7.5% run up? (so far)......I'm not sure whether you made it up to grade 4 or 5 math, but either way, according to my calculations, your brilliant strategy is losing you money, and all you seem to be concentrating on is my "dinghy"....sorry to break it to you, Quenty, but I play for the home team.....but good luck with your strategy....you're probably better off to wait until October to get back in....you know....just to be safe...lol

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record